These results identify TP63γ as an unfavorable prognostic marker in HNSCC, and identify PTBP1 as the first direct splicing regulator of TP63γ production and a potential route toward p63 isoforms control. The gene discussed is PTBP1; the disease is head and neck squamous cell carcinoma.